The global asthma report 2018. Auckland, New Zealand: Global Asthma Network. 2018.
Akinbami L. The state of childhood asthma, United States, 1980–2005. Adv Data. 2006;381:1–24.
Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229–35.
Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–23.
Wu W, Bleecker E, Moore W, Busse WW, Castro M, Chung KF, et al. Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol. 2014;133(5):1280–8.
Molfino NA. Targeting of eosinophils in asthma. Expert Opin Biol Ther. 2012;12(7):807–9.
Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033–9.
Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1532–9.
Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002;19(1):68–75.
Sykes A, Johnston SL. Etiology of asthma exacerbations. J Allergy Clin Immunol. 2008;122(4):685–8.
Nakagome K, Nagata M. Involvement and possible role of eosinophils in asthma exacerbation. Front Immunol. 2018;9:2220.
Busse WW. A role for neutrophils in asthma exacerbations. Nat Med. 2017;23(6):658–9.
Zeiger RS, Schatz M, Dalal AA, Chen W, Sadikova E, Suruki RY, et al. Blood eosinophil count and outcomes in severe uncontrolled asthma: a prospective study. J Allergy Clin Immunol Pract. 2017;5(1):144-53.e8.
Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849–58.
Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, et al. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2(6):741–50.
Casciano J, Krishnan JA, Small MB, Buck PO, Gopalan G, et al. Burden of asthma with elevated blood eosinophil levels. BMC Pulm Med. 2016;16(1):100.
Shi G, Zhao JW, Ming L. Clinical significance of peripheral blood neutrophil–lymphocyte ratio and platelet-lymphocyte ratio in patients with asthma. Nan fang yi ke da xue xue bao. 2017;37(1):84–8.
Mochimaru T, Ueda S, Suzuki Y, Asano K, Fukunaga K. Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma. Ann Allergy Asthma Immunol. 2019;122(3):337.e1-339.e1.
National Asthma Education and Program Prevention. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 2007;120(5 Suppl):S94–138.
European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22(3):470–7.
Green RH, Brightling CE, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol. 2007;7(1):43–50.
Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002;57(10):875–9.
Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol. 2004;113(1):101–8.
Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651–9.
Naylor S. Biomarkers: current perspectives and future prospects. Expert Rev Mol Diagn. 2003;3(5):525–9.
Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1–12.
Makela MJ, Christensen HN, Karlsson A, Rastogi S, Kettunen K. Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland. Eur Clin Respir J. 2018;5(1):1458560.
Pola-Bibian B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, Gonzalez-Cavero L, Barranco P, et al. Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization. J Investig Allergol Clin Immunol. 2016. https://doi.org/10.18176/jiaci.0128.
Bedolla-Barajas M, Raul Ortiz-Peregrina J, Daniel Hernandez-Colin D, Morales-Romero J, Ramses Bedolla-Pulido T, Larenas-Linnemann D. The characterization of asthma with blood eosinophilia in adults in Latin America. J Asthma. 2018;56:1–9.
Lakupoch K, Manuyakorn W, Preutthipan A, Kamalaporn H. The effectiveness of newly developed written asthma action plan in improvement of asthma outcome in children. Asian Pac J Allergy Immunol. 2018;36(2):88–92.
Goronfolah L, Abulaban A, Barnawi AI, Jawi M, Alhadhrami W, Baatiah NY. The effectiveness of written asthma action plan at the National Guard Health Affairs’ Asthma Clinic. Cureus. 2019;11(11):e6247.
Andropoulos DB. “Appendix B: pediatric normal laboratory values” in Gregory’s pediatric anesthesia. 5th ed. Oxford: Blackwell Publishing; 2012.
Li J, Chen Q, Luo X, Hong J, Pan K, Lin X, et al. Neutrophil-to-lymphocyte ratio positively correlates to age in healthy population. J Clin Lab Anal. 2015;29(6):437–43.
Nacaroglu HT, İsgüder R, Bent S, Erdem Bahceci S, Ceylan G, Korkmaz HA, et al. Can neutrophil/lymphocyte ratio be a novel biomarker of inflammation in children with asthma? Eur J Inflamm. 2016;14(2):109–12.
Huang Y, Liu A, Liang L, Jiang J, Luo H, Deng W, et al. Diagnostic value of blood parameters for community-acquired pneumonia. Int Immunopharmacol. 2018;64:10–5.
de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, et al. The neutrophil–lymphocyte count ratio in patients with community-acquired pneumonia. PLoS ONE. 2012;7(10):e46561.
Vanderweil SG, Tsai CL, Pelletier AJ, Espinola JA, Sullivan AF, Blumenthal D, et al. Inappropriate use of antibiotics for acute asthma in United States emergency departments. Acad Emerg Med. 2008;15(8):736–43.
Darmon D, Laforest L, Van Ganse E, Petrazzuoli F, van Weel C, Letrilliart L. Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data. BMC Fam Pract. 2015;16:14.